Global Tetanus Vaccine (Adsorbed) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

June 2026 | 120 pages | ID: GA025E9A9B54EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Tetanus Vaccine (Adsorbed) market size was valued at US$ 5659 million in 2025 and is forecast to a readjusted size of US$ 6998 million by 2032 with a CAGR of 3.3% during review period.

In 2025, global Tetanus Vaccine (Adsorbed) production reached approximately 250 million units, with an average global market price of around US$22 per unit. Tetanus Vaccine (Adsorbed) is a preparation of Tetanus formol toxoid adsorbed on aluminium phosphate gel. Thiomersal is used as a preservative. The potency is not less than 40 International Units per single human dose.

The global market for adsorbed tetanus vaccine maintains steady growth, driven by the rigid demand for post-traumatic prevention and continuous improvement of national immunization programs. The neonatal tetanus elimination goal promoted by the World Health Organization has significantly increased vaccination rates in low-income countries, and centralized procurement by international organizations provides stable support for these markets. Combination vaccines dominate the pediatric basic immunization market, while monovalent vaccines play an irreplaceable role in adult booster immunization and post-traumatic emergency prevention. Vaccine production technology is upgrading, with high-purity antigen preparation processes and new adjuvants improving immunogenicity and safety, and the proportion of pre-filled syringe formulations gradually increasing. Market development varies across regions, with growth in high-income countries mainly coming from increased adult immunization coverage, while low- and middle-income countries rely on further improvement of basic immunization rates. Global regulators continue to tighten vaccine quality and production standards, raising industry entry barriers. Future market growth will be driven by the release of adult booster immunization demand and iterative upgrades of combination vaccine products.

This report is a detailed and comprehensive analysis for global Tetanus Vaccine (Adsorbed) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Tetanus Vaccine (Adsorbed) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032

Global Tetanus Vaccine (Adsorbed) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032

Global Tetanus Vaccine (Adsorbed) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032

Global Tetanus Vaccine (Adsorbed) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026

The Primary Objectives in This Report Are:
  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Tetanus Vaccine (Adsorbed)
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace
This report profiles key players in the global Tetanus Vaccine (Adsorbed) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GSK, Bio Farma, Serum Institute of India, MassBiologics, Panacea Biotec, KM Biologics, BIKEN, Chengdu Oulin Biological, Wuhan Biological Products, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Tetanus Vaccine (Adsorbed) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • Tetanus Vaccine
  • Combined Vaccine
Market segment by Function
  • Basic Vaccines
  • Booster Vaccines
Market segment by Target Population
  • Children
  • Adults
  • Teenagers
Market segment by Application
  • Hospital
  • Clinic
Major players covered
  • Sanofi
  • GSK
  • Bio Farma
  • Serum Institute of India
  • MassBiologics
  • Panacea Biotec
  • KM Biologics
  • BIKEN
  • Chengdu Oulin Biological
  • Wuhan Biological Products
  • Hualan Biological Bacterin
  • Chengdu Institute of Biological Products
  • Beijing Institute of Biological Products
Market segment by region, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Tetanus Vaccine (Adsorbed) product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Tetanus Vaccine (Adsorbed), with price, sales quantity, revenue, and global market share of Tetanus Vaccine (Adsorbed) from 2021 to 2026.

Chapter 3, the Tetanus Vaccine (Adsorbed) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Tetanus Vaccine (Adsorbed) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Tetanus Vaccine (Adsorbed) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Tetanus Vaccine (Adsorbed).

Chapter 14 and 15, to describe Tetanus Vaccine (Adsorbed) sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Tetanus Vaccine (Adsorbed) Consumption Value by Type: 2021 Versus 2025 Versus 2032
  1.3.2 Tetanus Vaccine
  1.3.3 Combined Vaccine
1.4 Market Analysis by Function
  1.4.1 Overview: Global Tetanus Vaccine (Adsorbed) Consumption Value by Function: 2021 Versus 2025 Versus 2032
  1.4.2 Basic Vaccines
  1.4.3 Booster Vaccines
1.5 Market Analysis by Target Population
  1.5.1 Overview: Global Tetanus Vaccine (Adsorbed) Consumption Value by Target Population: 2021 Versus 2025 Versus 2032
  1.5.2 Children
  1.5.3 Adults
  1.5.4 Teenagers
1.6 Market Analysis by Application
  1.6.1 Overview: Global Tetanus Vaccine (Adsorbed) Consumption Value by Application: 2021 Versus 2025 Versus 2032
  1.6.2 Hospital
  1.6.3 Clinic
1.7 Global Tetanus Vaccine (Adsorbed) Market Size & Forecast
  1.7.1 Global Tetanus Vaccine (Adsorbed) Consumption Value (2021 & 2025 & 2032)
  1.7.2 Global Tetanus Vaccine (Adsorbed) Sales Quantity (2021-2032)
  1.7.3 Global Tetanus Vaccine (Adsorbed) Average Price (2021-2032)

2 MANUFACTURERS PROFILES

2.1 Sanofi
  2.1.1 Sanofi Details
  2.1.2 Sanofi Major Business
  2.1.3 Sanofi Tetanus Vaccine (Adsorbed) Product and Services
  2.1.4 Sanofi Tetanus Vaccine (Adsorbed) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.1.5 Sanofi Recent Developments/Updates
2.2 GSK
  2.2.1 GSK Details
  2.2.2 GSK Major Business
  2.2.3 GSK Tetanus Vaccine (Adsorbed) Product and Services
  2.2.4 GSK Tetanus Vaccine (Adsorbed) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.2.5 GSK Recent Developments/Updates
2.3 Bio Farma
  2.3.1 Bio Farma Details
  2.3.2 Bio Farma Major Business
  2.3.3 Bio Farma Tetanus Vaccine (Adsorbed) Product and Services
  2.3.4 Bio Farma Tetanus Vaccine (Adsorbed) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.3.5 Bio Farma Recent Developments/Updates
2.4 Serum Institute of India
  2.4.1 Serum Institute of India Details
  2.4.2 Serum Institute of India Major Business
  2.4.3 Serum Institute of India Tetanus Vaccine (Adsorbed) Product and Services
  2.4.4 Serum Institute of India Tetanus Vaccine (Adsorbed) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.4.5 Serum Institute of India Recent Developments/Updates
2.5 MassBiologics
  2.5.1 MassBiologics Details
  2.5.2 MassBiologics Major Business
  2.5.3 MassBiologics Tetanus Vaccine (Adsorbed) Product and Services
  2.5.4 MassBiologics Tetanus Vaccine (Adsorbed) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.5.5 MassBiologics Recent Developments/Updates
2.6 Panacea Biotec
  2.6.1 Panacea Biotec Details
  2.6.2 Panacea Biotec Major Business
  2.6.3 Panacea Biotec Tetanus Vaccine (Adsorbed) Product and Services
  2.6.4 Panacea Biotec Tetanus Vaccine (Adsorbed) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.6.5 Panacea Biotec Recent Developments/Updates
2.7 KM Biologics
  2.7.1 KM Biologics Details
  2.7.2 KM Biologics Major Business
  2.7.3 KM Biologics Tetanus Vaccine (Adsorbed) Product and Services
  2.7.4 KM Biologics Tetanus Vaccine (Adsorbed) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.7.5 KM Biologics Recent Developments/Updates
2.8 BIKEN
  2.8.1 BIKEN Details
  2.8.2 BIKEN Major Business
  2.8.3 BIKEN Tetanus Vaccine (Adsorbed) Product and Services
  2.8.4 BIKEN Tetanus Vaccine (Adsorbed) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.8.5 BIKEN Recent Developments/Updates
2.9 Chengdu Oulin Biological
  2.9.1 Chengdu Oulin Biological Details
  2.9.2 Chengdu Oulin Biological Major Business
  2.9.3 Chengdu Oulin Biological Tetanus Vaccine (Adsorbed) Product and Services
  2.9.4 Chengdu Oulin Biological Tetanus Vaccine (Adsorbed) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.9.5 Chengdu Oulin Biological Recent Developments/Updates
2.10 Wuhan Biological Products
  2.10.1 Wuhan Biological Products Details
  2.10.2 Wuhan Biological Products Major Business
  2.10.3 Wuhan Biological Products Tetanus Vaccine (Adsorbed) Product and Services
  2.10.4 Wuhan Biological Products Tetanus Vaccine (Adsorbed) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.10.5 Wuhan Biological Products Recent Developments/Updates
2.11 Hualan Biological Bacterin
  2.11.1 Hualan Biological Bacterin Details
  2.11.2 Hualan Biological Bacterin Major Business
  2.11.3 Hualan Biological Bacterin Tetanus Vaccine (Adsorbed) Product and Services
  2.11.4 Hualan Biological Bacterin Tetanus Vaccine (Adsorbed) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.11.5 Hualan Biological Bacterin Recent Developments/Updates
2.12 Chengdu Institute of Biological Products
  2.12.1 Chengdu Institute of Biological Products Details
  2.12.2 Chengdu Institute of Biological Products Major Business
  2.12.3 Chengdu Institute of Biological Products Tetanus Vaccine (Adsorbed) Product and Services
  2.12.4 Chengdu Institute of Biological Products Tetanus Vaccine (Adsorbed) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.12.5 Chengdu Institute of Biological Products Recent Developments/Updates
2.13 Beijing Institute of Biological Products
  2.13.1 Beijing Institute of Biological Products Details
  2.13.2 Beijing Institute of Biological Products Major Business
  2.13.3 Beijing Institute of Biological Products Tetanus Vaccine (Adsorbed) Product and Services
  2.13.4 Beijing Institute of Biological Products Tetanus Vaccine (Adsorbed) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.13.5 Beijing Institute of Biological Products Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: TETANUS VACCINE (ADSORBED) BY MANUFACTURER

3.1 Global Tetanus Vaccine (Adsorbed) Sales Quantity by Manufacturer (2021-2026)
3.2 Global Tetanus Vaccine (Adsorbed) Revenue by Manufacturer (2021-2026)
3.3 Global Tetanus Vaccine (Adsorbed) Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
  3.4.1 Producer Shipments of Tetanus Vaccine (Adsorbed) by Manufacturer Revenue ($MM) and Market Share (%): 2025
  3.4.2 Top 3 Tetanus Vaccine (Adsorbed) Manufacturer Market Share in 2025
  3.4.3 Top 6 Tetanus Vaccine (Adsorbed) Manufacturer Market Share in 2025
3.5 Tetanus Vaccine (Adsorbed) Market: Overall Company Footprint Analysis
  3.5.1 Tetanus Vaccine (Adsorbed) Market: Region Footprint
  3.5.2 Tetanus Vaccine (Adsorbed) Market: Company Product Type Footprint
  3.5.3 Tetanus Vaccine (Adsorbed) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Tetanus Vaccine (Adsorbed) Market Size by Region
  4.1.1 Global Tetanus Vaccine (Adsorbed) Sales Quantity by Region (2021-2032)
  4.1.2 Global Tetanus Vaccine (Adsorbed) Consumption Value by Region (2021-2032)
  4.1.3 Global Tetanus Vaccine (Adsorbed) Average Price by Region (2021-2032)
4.2 North America Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032)
4.3 Europe Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032)
4.4 Asia-Pacific Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032)
4.5 South America Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032)
4.6 Middle East & Africa Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032)

5 MARKET SEGMENT BY TYPE

5.1 Global Tetanus Vaccine (Adsorbed) Sales Quantity by Type (2021-2032)
5.2 Global Tetanus Vaccine (Adsorbed) Consumption Value by Type (2021-2032)
5.3 Global Tetanus Vaccine (Adsorbed) Average Price by Type (2021-2032)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Tetanus Vaccine (Adsorbed) Sales Quantity by Application (2021-2032)
6.2 Global Tetanus Vaccine (Adsorbed) Consumption Value by Application (2021-2032)
6.3 Global Tetanus Vaccine (Adsorbed) Average Price by Application (2021-2032)

7 NORTH AMERICA

7.1 North America Tetanus Vaccine (Adsorbed) Sales Quantity by Type (2021-2032)
7.2 North America Tetanus Vaccine (Adsorbed) Sales Quantity by Application (2021-2032)
7.3 North America Tetanus Vaccine (Adsorbed) Market Size by Country
  7.3.1 North America Tetanus Vaccine (Adsorbed) Sales Quantity by Country (2021-2032)
  7.3.2 North America Tetanus Vaccine (Adsorbed) Consumption Value by Country (2021-2032)
  7.3.3 United States Market Size and Forecast (2021-2032)
  7.3.4 Canada Market Size and Forecast (2021-2032)
  7.3.5 Mexico Market Size and Forecast (2021-2032)

8 EUROPE

8.1 Europe Tetanus Vaccine (Adsorbed) Sales Quantity by Type (2021-2032)
8.2 Europe Tetanus Vaccine (Adsorbed) Sales Quantity by Application (2021-2032)
8.3 Europe Tetanus Vaccine (Adsorbed) Market Size by Country
  8.3.1 Europe Tetanus Vaccine (Adsorbed) Sales Quantity by Country (2021-2032)
  8.3.2 Europe Tetanus Vaccine (Adsorbed) Consumption Value by Country (2021-2032)
  8.3.3 Germany Market Size and Forecast (2021-2032)
  8.3.4 France Market Size and Forecast (2021-2032)
  8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  8.3.6 Russia Market Size and Forecast (2021-2032)
  8.3.7 Italy Market Size and Forecast (2021-2032)

9 ASIA-PACIFIC

9.1 Asia-Pacific Tetanus Vaccine (Adsorbed) Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Tetanus Vaccine (Adsorbed) Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Tetanus Vaccine (Adsorbed) Market Size by Region
  9.3.1 Asia-Pacific Tetanus Vaccine (Adsorbed) Sales Quantity by Region (2021-2032)
  9.3.2 Asia-Pacific Tetanus Vaccine (Adsorbed) Consumption Value by Region (2021-2032)
  9.3.3 China Market Size and Forecast (2021-2032)
  9.3.4 Japan Market Size and Forecast (2021-2032)
  9.3.5 South Korea Market Size and Forecast (2021-2032)
  9.3.6 India Market Size and Forecast (2021-2032)
  9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  9.3.8 Australia Market Size and Forecast (2021-2032)

10 SOUTH AMERICA

10.1 South America Tetanus Vaccine (Adsorbed) Sales Quantity by Type (2021-2032)
10.2 South America Tetanus Vaccine (Adsorbed) Sales Quantity by Application (2021-2032)
10.3 South America Tetanus Vaccine (Adsorbed) Market Size by Country
  10.3.1 South America Tetanus Vaccine (Adsorbed) Sales Quantity by Country (2021-2032)
  10.3.2 South America Tetanus Vaccine (Adsorbed) Consumption Value by Country (2021-2032)
  10.3.3 Brazil Market Size and Forecast (2021-2032)
  10.3.4 Argentina Market Size and Forecast (2021-2032)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Tetanus Vaccine (Adsorbed) Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Tetanus Vaccine (Adsorbed) Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Tetanus Vaccine (Adsorbed) Market Size by Country
  11.3.1 Middle East & Africa Tetanus Vaccine (Adsorbed) Sales Quantity by Country (2021-2032)
  11.3.2 Middle East & Africa Tetanus Vaccine (Adsorbed) Consumption Value by Country (2021-2032)
  11.3.3 Turkey Market Size and Forecast (2021-2032)
  11.3.4 Egypt Market Size and Forecast (2021-2032)
  11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  11.3.6 South Africa Market Size and Forecast (2021-2032)

12 MARKET DYNAMICS

12.1 Tetanus Vaccine (Adsorbed) Market Drivers
12.2 Tetanus Vaccine (Adsorbed) Market Restraints
12.3 Tetanus Vaccine (Adsorbed) Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Tetanus Vaccine (Adsorbed) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Tetanus Vaccine (Adsorbed)
13.3 Tetanus Vaccine (Adsorbed) Production Process
13.4 Industry Value Chain Analysis

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Tetanus Vaccine (Adsorbed) Typical Distributors
14.3 Tetanus Vaccine (Adsorbed) Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES

Table 1. Global Tetanus Vaccine (Adsorbed) Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Tetanus Vaccine (Adsorbed) Consumption Value by Function, (USD Million), 2021 & 2025 & 2032
Table 3. Global Tetanus Vaccine (Adsorbed) Consumption Value by Target Population, (USD Million), 2021 & 2025 & 2032
Table 4. Global Tetanus Vaccine (Adsorbed) Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Sanofi Basic Information, Manufacturing Base and Competitors
Table 6. Sanofi Major Business
Table 7. Sanofi Tetanus Vaccine (Adsorbed) Product and Services
Table 8. Sanofi Tetanus Vaccine (Adsorbed) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Sanofi Recent Developments/Updates
Table 10. GSK Basic Information, Manufacturing Base and Competitors
Table 11. GSK Major Business
Table 12. GSK Tetanus Vaccine (Adsorbed) Product and Services
Table 13. GSK Tetanus Vaccine (Adsorbed) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. GSK Recent Developments/Updates
Table 15. Bio Farma Basic Information, Manufacturing Base and Competitors
Table 16. Bio Farma Major Business
Table 17. Bio Farma Tetanus Vaccine (Adsorbed) Product and Services
Table 18. Bio Farma Tetanus Vaccine (Adsorbed) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Bio Farma Recent Developments/Updates
Table 20. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 21. Serum Institute of India Major Business
Table 22. Serum Institute of India Tetanus Vaccine (Adsorbed) Product and Services
Table 23. Serum Institute of India Tetanus Vaccine (Adsorbed) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Serum Institute of India Recent Developments/Updates
Table 25. MassBiologics Basic Information, Manufacturing Base and Competitors
Table 26. MassBiologics Major Business
Table 27. MassBiologics Tetanus Vaccine (Adsorbed) Product and Services
Table 28. MassBiologics Tetanus Vaccine (Adsorbed) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. MassBiologics Recent Developments/Updates
Table 30. Panacea Biotec Basic Information, Manufacturing Base and Competitors
Table 31. Panacea Biotec Major Business
Table 32. Panacea Biotec Tetanus Vaccine (Adsorbed) Product and Services
Table 33. Panacea Biotec Tetanus Vaccine (Adsorbed) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Panacea Biotec Recent Developments/Updates
Table 35. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 36. KM Biologics Major Business
Table 37. KM Biologics Tetanus Vaccine (Adsorbed) Product and Services
Table 38. KM Biologics Tetanus Vaccine (Adsorbed) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. KM Biologics Recent Developments/Updates
Table 40. BIKEN Basic Information, Manufacturing Base and Competitors
Table 41. BIKEN Major Business
Table 42. BIKEN Tetanus Vaccine (Adsorbed) Product and Services
Table 43. BIKEN Tetanus Vaccine (Adsorbed) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. BIKEN Recent Developments/Updates
Table 45. Chengdu Oulin Biological Basic Information, Manufacturing Base and Competitors
Table 46. Chengdu Oulin Biological Major Business
Table 47. Chengdu Oulin Biological Tetanus Vaccine (Adsorbed) Product and Services
Table 48. Chengdu Oulin Biological Tetanus Vaccine (Adsorbed) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Chengdu Oulin Biological Recent Developments/Updates
Table 50. Wuhan Biological Products Basic Information, Manufacturing Base and Competitors
Table 51. Wuhan Biological Products Major Business
Table 52. Wuhan Biological Products Tetanus Vaccine (Adsorbed) Product and Services
Table 53. Wuhan Biological Products Tetanus Vaccine (Adsorbed) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Wuhan Biological Products Recent Developments/Updates
Table 55. Hualan Biological Bacterin Basic Information, Manufacturing Base and Competitors
Table 56. Hualan Biological Bacterin Major Business
Table 57. Hualan Biological Bacterin Tetanus Vaccine (Adsorbed) Product and Services
Table 58. Hualan Biological Bacterin Tetanus Vaccine (Adsorbed) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Hualan Biological Bacterin Recent Developments/Updates
Table 60. Chengdu Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 61. Chengdu Institute of Biological Products Major Business
Table 62. Chengdu Institute of Biological Products Tetanus Vaccine (Adsorbed) Product and Services
Table 63. Chengdu Institute of Biological Products Tetanus Vaccine (Adsorbed) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Chengdu Institute of Biological Products Recent Developments/Updates
Table 65. Beijing Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 66. Beijing Institute of Biological Products Major Business
Table 67. Beijing Institute of Biological Products Tetanus Vaccine (Adsorbed) Product and Services
Table 68. Beijing Institute of Biological Products Tetanus Vaccine (Adsorbed) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Beijing Institute of Biological Products Recent Developments/Updates
Table 70. Global Tetanus Vaccine (Adsorbed) Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 71. Global Tetanus Vaccine (Adsorbed) Revenue by Manufacturer (2021-2026) & (USD Million)
Table 72. Global Tetanus Vaccine (Adsorbed) Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 73. Market Position of Manufacturers in Tetanus Vaccine (Adsorbed), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 74. Head Office and Tetanus Vaccine (Adsorbed) Production Site of Key Manufacturer
Table 75. Tetanus Vaccine (Adsorbed) Market: Company Product Type Footprint
Table 76. Tetanus Vaccine (Adsorbed) Market: Company Product Application Footprint
Table 77. Tetanus Vaccine (Adsorbed) New Market Entrants and Barriers to Market Entry
Table 78. Tetanus Vaccine (Adsorbed) Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Tetanus Vaccine (Adsorbed) Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 80. Global Tetanus Vaccine (Adsorbed) Sales Quantity by Region (2021-2026) & (K Units)
Table 81. Global Tetanus Vaccine (Adsorbed) Sales Quantity by Region (2027-2032) & (K Units)
Table 82. Global Tetanus Vaccine (Adsorbed) Consumption Value by Region (2021-2026) & (USD Million)
Table 83. Global Tetanus Vaccine (Adsorbed) Consumption Value by Region (2027-2032) & (USD Million)
Table 84. Global Tetanus Vaccine (Adsorbed) Average Price by Region (2021-2026) & (US$/Unit)
Table 85. Global Tetanus Vaccine (Adsorbed) Average Price by Region (2027-2032) & (US$/Unit)
Table 86. Global Tetanus Vaccine (Adsorbed) Sales Quantity by Type (2021-2026) & (K Units)
Table 87. Global Tetanus Vaccine (Adsorbed) Sales Quantity by Type (2027-2032) & (K Units)
Table 88. Global Tetanus Vaccine (Adsorbed) Consumption Value by Type (2021-2026) & (USD Million)
Table 89. Global Tetanus Vaccine (Adsorbed) Consumption Value by Type (2027-2032) & (USD Million)
Table 90. Global Tetanus Vaccine (Adsorbed) Average Price by Type (2021-2026) & (US$/Unit)
Table 91. Global Tetanus Vaccine (Adsorbed) Average Price by Type (2027-2032) & (US$/Unit)
Table 92. Global Tetanus Vaccine (Adsorbed) Sales Quantity by Application (2021-2026) & (K Units)
Table 93. Global Tetanus Vaccine (Adsorbed) Sales Quantity by Application (2027-2032) & (K Units)
Table 94. Global Tetanus Vaccine (Adsorbed) Consumption Value by Application (2021-2026) & (USD Million)
Table 95. Global Tetanus Vaccine (Adsorbed) Consumption Value by Application (2027-2032) & (USD Million)
Table 96. Global Tetanus Vaccine (Adsorbed) Average Price by Application (2021-2026) & (US$/Unit)
Table 97. Global Tetanus Vaccine (Adsorbed) Average Price by Application (2027-2032) & (US$/Unit)
Table 98. North America Tetanus Vaccine (Adsorbed) Sales Quantity by Type (2021-2026) & (K Units)
Table 99. North America Tetanus Vaccine (Adsorbed) Sales Quantity by Type (2027-2032) & (K Units)
Table 100. North America Tetanus Vaccine (Adsorbed) Sales Quantity by Application (2021-2026) & (K Units)
Table 101. North America Tetanus Vaccine (Adsorbed) Sales Quantity by Application (2027-2032) & (K Units)
Table 102. North America Tetanus Vaccine (Adsorbed) Sales Quantity by Country (2021-2026) & (K Units)
Table 103. North America Tetanus Vaccine (Adsorbed) Sales Quantity by Country (2027-2032) & (K Units)
Table 104. North America Tetanus Vaccine (Adsorbed) Consumption Value by Country (2021-2026) & (USD Million)
Table 105. North America Tetanus Vaccine (Adsorbed) Consumption Value by Country (2027-2032) & (USD Million)
Table 106. Europe Tetanus Vaccine (Adsorbed) Sales Quantity by Type (2021-2026) & (K Units)
Table 107. Europe Tetanus Vaccine (Adsorbed) Sales Quantity by Type (2027-2032) & (K Units)
Table 108. Europe Tetanus Vaccine (Adsorbed) Sales Quantity by Application (2021-2026) & (K Units)
Table 109. Europe Tetanus Vaccine (Adsorbed) Sales Quantity by Application (2027-2032) & (K Units)
Table 110. Europe Tetanus Vaccine (Adsorbed) Sales Quantity by Country (2021-2026) & (K Units)
Table 111. Europe Tetanus Vaccine (Adsorbed) Sales Quantity by Country (2027-2032) & (K Units)
Table 112. Europe Tetanus Vaccine (Adsorbed) Consumption Value by Country (2021-2026) & (USD Million)
Table 113. Europe Tetanus Vaccine (Adsorbed) Consumption Value by Country (2027-2032) & (USD Million)
Table 114. Asia-Pacific Tetanus Vaccine (Adsorbed) Sales Quantity by Type (2021-2026) & (K Units)
Table 115. Asia-Pacific Tetanus Vaccine (Adsorbed) Sales Quantity by Type (2027-2032) & (K Units)
Table 116. Asia-Pacific Tetanus Vaccine (Adsorbed) Sales Quantity by Application (2021-2026) & (K Units)
Table 117. Asia-Pacific Tetanus Vaccine (Adsorbed) Sales Quantity by Application (2027-2032) & (K Units)
Table 118. Asia-Pacific Tetanus Vaccine (Adsorbed) Sales Quantity by Region (2021-2026) & (K Units)
Table 119. Asia-Pacific Tetanus Vaccine (Adsorbed) Sales Quantity by Region (2027-2032) & (K Units)
Table 120. Asia-Pacific Tetanus Vaccine (Adsorbed) Consumption Value by Region (2021-2026) & (USD Million)
Table 121. Asia-Pacific Tetanus Vaccine (Adsorbed) Consumption Value by Region (2027-2032) & (USD Million)
Table 122. South America Tetanus Vaccine (Adsorbed) Sales Quantity by Type (2021-2026) & (K Units)
Table 123. South America Tetanus Vaccine (Adsorbed) Sales Quantity by Type (2027-2032) & (K Units)
Table 124. South America Tetanus Vaccine (Adsorbed) Sales Quantity by Application (2021-2026) & (K Units)
Table 125. South America Tetanus Vaccine (Adsorbed) Sales Quantity by Application (2027-2032) & (K Units)
Table 126. South America Tetanus Vaccine (Adsorbed) Sales Quantity by Country (2021-2026) & (K Units)
Table 127. South America Tetanus Vaccine (Adsorbed) Sales Quantity by Country (2027-2032) & (K Units)
Table 128. South America Tetanus Vaccine (Adsorbed) Consumption Value by Country (2021-2026) & (USD Million)
Table 129. South America Tetanus Vaccine (Adsorbed) Consumption Value by Country (2027-2032) & (USD Million)
Table 130. Middle East & Africa Tetanus Vaccine (Adsorbed) Sales Quantity by Type (2021-2026) & (K Units)
Table 131. Middle East & Africa Tetanus Vaccine (Adsorbed) Sales Quantity by Type (2027-2032) & (K Units)
Table 132. Middle East & Africa Tetanus Vaccine (Adsorbed) Sales Quantity by Application (2021-2026) & (K Units)
Table 133. Middle East & Africa Tetanus Vaccine (Adsorbed) Sales Quantity by Application (2027-2032) & (K Units)
Table 134. Middle East & Africa Tetanus Vaccine (Adsorbed) Sales Quantity by Country (2021-2026) & (K Units)
Table 135. Middle East & Africa Tetanus Vaccine (Adsorbed) Sales Quantity by Country (2027-2032) & (K Units)
Table 136. Middle East & Africa Tetanus Vaccine (Adsorbed) Consumption Value by Country (2021-2026) & (USD Million)
Table 137. Middle East & Africa Tetanus Vaccine (Adsorbed) Consumption Value by Country (2027-2032) & (USD Million)
Table 138. Tetanus Vaccine (Adsorbed) Raw Material
Table 139. Key Manufacturers of Tetanus Vaccine (Adsorbed) Raw Materials
Table 140. Tetanus Vaccine (Adsorbed) Typical Distributors
Table 141. Tetanus Vaccine (Adsorbed) Typical Customers

LIST OF FIGURES

Figure 1. Tetanus Vaccine (Adsorbed) Picture
Figure 2. Global Tetanus Vaccine (Adsorbed) Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Type in 2025
Figure 4. Tetanus Vaccine Examples
Figure 5. Combined Vaccine Examples
Figure 6. Global Tetanus Vaccine (Adsorbed) Revenue by Function, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Function in 2025
Figure 8. Basic Vaccines Examples
Figure 9. Booster Vaccines Examples
Figure 10. Global Tetanus Vaccine (Adsorbed) Revenue by Target Population, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Target Population in 2025
Figure 12. Children Examples
Figure 13. Adults Examples
Figure 14. Teenagers Examples
Figure 15. Global Tetanus Vaccine (Adsorbed) Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 16. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Application in 2025
Figure 17. Hospital Examples
Figure 18. Clinic Examples
Figure 19. Global Tetanus Vaccine (Adsorbed) Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 20. Global Tetanus Vaccine (Adsorbed) Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 21. Global Tetanus Vaccine (Adsorbed) Sales Quantity (2021-2032) & (K Units)
Figure 22. Global Tetanus Vaccine (Adsorbed) Price (2021-2032) & (US$/Unit)
Figure 23. Global Tetanus Vaccine (Adsorbed) Sales Quantity Market Share by Manufacturer in 2025
Figure 24. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Manufacturer in 2025
Figure 25. Producer Shipments of Tetanus Vaccine (Adsorbed) by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 26. Top 3 Tetanus Vaccine (Adsorbed) Manufacturer (Revenue) Market Share in 2025
Figure 27. Top 6 Tetanus Vaccine (Adsorbed) Manufacturer (Revenue) Market Share in 2025
Figure 28. Global Tetanus Vaccine (Adsorbed) Sales Quantity Market Share by Region (2021-2032)
Figure 29. Global Tetanus Vaccine (Adsorbed) Consumption Value Market Share by Region (2021-2032)
Figure 30. North America Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 31. Europe Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 32. Asia-Pacific Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 33. South America Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 34. Middle East & Africa Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 35. Global Tetanus Vaccine (Adsorbed) Sales Quantity Market Share by Type (2021-2032)
Figure 36. Global Tetanus Vaccine (Adsorbed) Consumption Value Market Share by Type (2021-2032)
Figure 37. Global Tetanus Vaccine (Adsorbed) Average Price by Type (2021-2032) & (US$/Unit)
Figure 38. Global Tetanus Vaccine (Adsorbed) Sales Quantity Market Share by Application (2021-2032)
Figure 39. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Application (2021-2032)
Figure 40. Global Tetanus Vaccine (Adsorbed) Average Price by Application (2021-2032) & (US$/Unit)
Figure 41. North America Tetanus Vaccine (Adsorbed) Sales Quantity Market Share by Type (2021-2032)
Figure 42. North America Tetanus Vaccine (Adsorbed) Sales Quantity Market Share by Application (2021-2032)
Figure 43. North America Tetanus Vaccine (Adsorbed) Sales Quantity Market Share by Country (2021-2032)
Figure 44. North America Tetanus Vaccine (Adsorbed) Consumption Value Market Share by Country (2021-2032)
Figure 45. United States Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Tetanus Vaccine (Adsorbed) Sales Quantity Market Share by Type (2021-2032)
Figure 49. Europe Tetanus Vaccine (Adsorbed) Sales Quantity Market Share by Application (2021-2032)
Figure 50. Europe Tetanus Vaccine (Adsorbed) Sales Quantity Market Share by Country (2021-2032)
Figure 51. Europe Tetanus Vaccine (Adsorbed) Consumption Value Market Share by Country (2021-2032)
Figure 52. Germany Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 53. France Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 54. United Kingdom Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 55. Russia Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 56. Italy Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 57. Asia-Pacific Tetanus Vaccine (Adsorbed) Sales Quantity Market Share by Type (2021-2032)
Figure 58. Asia-Pacific Tetanus Vaccine (Adsorbed) Sales Quantity Market Share by Application (2021-2032)
Figure 59. Asia-Pacific Tetanus Vaccine (Adsorbed) Sales Quantity Market Share by Region (2021-2032)
Figure 60. Asia-Pacific Tetanus Vaccine (Adsorbed) Consumption Value Market Share by Region (2021-2032)
Figure 61. China Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 62. Japan Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 63. South Korea Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 64. India Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 65. Southeast Asia Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 66. Australia Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 67. South America Tetanus Vaccine (Adsorbed) Sales Quantity Market Share by Type (2021-2032)
Figure 68. South America Tetanus Vaccine (Adsorbed) Sales Quantity Market Share by Application (2021-2032)
Figure 69. South America Tetanus Vaccine (Adsorbed) Sales Quantity Market Share by Country (2021-2032)
Figure 70. South America Tetanus Vaccine (Adsorbed) Consumption Value Market Share by Country (2021-2032)
Figure 71. Brazil Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 72. Argentina Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 73. Middle East & Africa Tetanus Vaccine (Adsorbed) Sales Quantity Market Share by Type (2021-2032)
Figure 74. Middle East & Africa Tetanus Vaccine (Adsorbed) Sales Quantity Market Share by Application (2021-2032)
Figure 75. Middle East & Africa Tetanus Vaccine (Adsorbed) Sales Quantity Market Share by Country (2021-2032)
Figure 76. Middle East & Africa Tetanus Vaccine (Adsorbed) Consumption Value Market Share by Country (2021-2032)
Figure 77. Turkey Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 78. Egypt Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 79. Saudi Arabia Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 80. South Africa Tetanus Vaccine (Adsorbed) Consumption Value (2021-2032) & (USD Million)
Figure 81. Tetanus Vaccine (Adsorbed) Market Drivers
Figure 82. Tetanus Vaccine (Adsorbed) Market Restraints
Figure 83. Tetanus Vaccine (Adsorbed) Market Trends
Figure 84. Porters Five Forces Analysis
Figure 85. Manufacturing Cost Structure Analysis of Tetanus Vaccine (Adsorbed) in 2025
Figure 86. Manufacturing Process Analysis of Tetanus Vaccine (Adsorbed)
Figure 87. Tetanus Vaccine (Adsorbed) Industrial Chain
Figure 88. Sales Channel: Direct to End-User vs Distributors
Figure 89. Direct Channel Pros & Cons
Figure 90. Indirect Channel Pros & Cons
Figure 91. Methodology
Figure 92. Research Process and Data Source


More Publications